BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33764248)

  • 1. Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs.
    Sung JH
    Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):969-986. PubMed ID: 33764248
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models.
    Lee SH; Choi N; Sung JH
    Expert Opin Drug Metab Toxicol; 2019 Dec; 15(12):1005-1019. PubMed ID: 31794278
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips.
    Prantil-Baun R; Novak R; Das D; Somayaji MR; Przekwas A; Ingber DE
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():37-64. PubMed ID: 29309256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on microfluidic multi-organ-on-a-chip systems for reproducing drug pharmacokinetics: the current state-of-the-art.
    Vasconez Martinez MG; Frauenlob M; Rothbauer M
    Expert Opin Drug Metab Toxicol; 2024 Jun; 20(6):459-471. PubMed ID: 38832686
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Fagerholm U; Hellberg S; Alvarsson J; Spjuth O
    Xenobiotica; 2022 Feb; 52(2):113-118. PubMed ID: 35238270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-based multi-organ chip for recapitulating organ interactions.
    Sung JH
    Methods Cell Biol; 2018; 146():183-197. PubMed ID: 30037461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules.
    Bassani D; Parrott NJ; Manevski N; Zhang JD
    Expert Opin Drug Discov; 2024 Jun; 19(6):683-698. PubMed ID: 38727016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.
    Rostami-Hodjegan A
    Clin Pharmacol Ther; 2012 Jul; 92(1):50-61. PubMed ID: 22644330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in in vitro skin-on-a-chip models for drug testing.
    Sung JH; Kim JJ
    Expert Opin Drug Metab Toxicol; 2023; 19(5):249-267. PubMed ID: 37379024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Development in Organ-On-A-Chip Technology.
    Joseph X; Akhil V; Arathi A; Mohanan PV
    J Pharm Sci; 2022 Jan; 111(1):18-31. PubMed ID: 34324944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between pharmacokinetics and toxicokinetics.
    Welling PG
    Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-on-a-Chip Technology for Reproducing Multiorgan Physiology.
    Lee SH; Sung JH
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 28945001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
    Poulin P; Haddad S
    J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a physiology-based model for the prediction of pharmacokinetics/toxicokinetics in rabbits.
    Mavroudis PD; Hermes HE; Teutonico D; Preuss TG; Schneckener S
    PLoS One; 2018; 13(3):e0194294. PubMed ID: 29561908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling.
    Abaci HE; Shuler ML
    Integr Biol (Camb); 2015 Apr; 7(4):383-91. PubMed ID: 25739725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of human pharmacokinetics in 2013 and beyond.
    Houston JB
    Drug Metab Dispos; 2013 Dec; 41(12):1973-4. PubMed ID: 24130368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput PBTK models for
    Breen M; Ring CL; Kreutz A; Goldsmith MR; Wambaugh JF
    Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):903-921. PubMed ID: 34056988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling.
    Sung JH; Esch MB; Shuler ML
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1063-81. PubMed ID: 20540627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
    Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
    Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.